Key result
SEPT9 amplification associates with higher breast tumor mortality by protecting nuclei from mechanical stress.
Why the study?
How invasively migrating cells protect the nucleus from intracellular forces when threading through confined interstitial spaces is poorly understood.
Does SEPT9 amplification protect the nucleus from genotoxic mechanical stress in migrating cells?
Does SEPT9 amplification protect the nucleus from genotoxic mechanical stress in migrating cells?
Septins act as a mechanoprotective element of the cytoskeleton, and SEPT9 amplification enhances tumor cell survival by preventing nuclear damage during migration.
SEPT9 may promote invasive breast cancer cell survival; hypothesis-generating for septin targeting, pending clinical validation.
Summary Invasively migrating cells thread their nucleus through confined interstitial spaces. How cells protect the nucleus from intracellular forces is poorly understood. Here, we show that the septin cytoskeleton buffers the actomyosin forces that power nuclear movement. Septin filaments comprising SEPT9, a septin amplified in breast cancer, align with perinuclear actomyosin cables which exhibit higher tensile stress during 3D confined migration through narrower pores. SEPT9 depletion amplifies actin stress during confined migration and after myosin II hyper-activation in non-migrating cells causing actin and nuclear envelope ruptures. Following confined migration, DNA breaks, nuclear blebs, micronuclei and cell death increase in SEPT9-depleted cells, phenotypes rescued by the oncogenic SEPT9 isoform 1. Clinicogenomic data reveal that SEPT9 amplification associates with lower genomic alteration in aggressive breast tumors and higher patient mortality. We propose that septins are a mechanoprotective element of the cytoskeleton, and SEPT9 amplification enhances tumor cell survival by preventing nuclear damage.
No takes yet. Share an insight, caveat, or question.
Mayca-Pozo et al. (2026) studied Breast cancer. SEPT9 amplification was evaluated on Genomic alteration and patient mortality. SEPT9 amplification associates with lower genomic alteration in aggressive breast tumors and higher patient mortality by buffering actomyosin forces to protect the nucleus from mechanical stress.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: